PMID: 15232471Jul 3, 2004Paper

Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections

Current Opinion in Ophthalmology
Francis S Mah

Abstract

The fourth-generation fluoroquinolones, moxifloxacin and gatifloxacin, were introduced in 2003 promising improved spectrum of activity and delayed development of resistance. Although these topical agents have recently been introduced in commercial form, there is already a growing body of evidence showing excellent potency in the war on ocular infections. The purpose of this review is to discuss the literature to date regarding these two agents. Since their introduction in 1990 in the United States, fluoroquinolones have rapidly become the standard of care in the topical antibiotic arena. Unfortunately, recent evidence has shown the widespread use of fluoroquinolones, not only in eye care, but also in agriculture, and general medical and surgical use, has lead to decreasing susceptibilities of important ocular bacterial pathogens. Moxifloxacin and gatifloxacin have improved potency and are able to overcome resistant isolates. These agents also provide improved penetration into ocular tissues. Moxifloxacin and gatifloxacin offer improved spectrum of activity, increased penetration into ocular tissues, and delayed propensity to the development of bacterial antibiotic resistance.

References

Dec 1, 1991·Archives of Ophthalmology·S X StevensH G Jensen
Feb 7, 1991·The New England Journal of Medicine·D C Hooper, J S Wolfson
Jul 1, 1989·Reviews of Infectious Diseases·J S Wolfson, D C Hooper
Apr 1, 1994·The Journal of Antimicrobial Chemotherapy·J M Domagala
Nov 1, 1996·American Journal of Ophthalmology·J L Davis
Mar 30, 2000·The Journal of the Acoustical Society of America·E de Boer, A L Nuttall
Sep 21, 2000·The Journal of Antimicrobial Chemotherapy·P Ball
Dec 12, 2001·Journal of Cataract and Refractive Surgery·M C García-SáenzC Carrasco-Font
Apr 5, 2002·American Journal of Ophthalmology·Rookaya MatherRegis P Kowalski
Apr 11, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Dalhoff, F-J Schmitz
Apr 19, 2003·The Journal of Antimicrobial Chemotherapy·Richard Wise
Jul 2, 2003·American Journal of Ophthalmology·Tulaya TungsiripatPeter J McDonnell

❮ Previous
Next ❯

Citations

Jul 22, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Majid MoshirfarNick Mamalis
Nov 16, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·K Keven WilliamsJoseph W Hiddemen
Jun 6, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Joel W ProkschKeith W Ward
Mar 26, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Bryan K MonsonRandall J Olson
Jun 23, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Erin W NorcrossMary E Marquart
Oct 12, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Richard LindstromNathan Teuscher
Oct 18, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·John SegretiJoseph S Bertino
Dec 20, 2012·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yoshitaka TasakaYuichi Ohashi
Jan 26, 2007·Cornea·Adália Dias Dourado OliveiraWaldemar Francisco
Sep 17, 2010·Journal of Periodontology·Thomas F FlemmigThomas Beikler
May 17, 2011·Clinical Ophthalmology·Lorenzo J Cervantes, Francis S Mah
Dec 4, 2014·Journal of Cataract and Refractive Surgery·Rosa Braga-MeleUNKNOWN ASCRS Clinical Cataract Committee
Aug 11, 2006·Pediatric Clinics of North America·Francis Mah
Mar 13, 2010·Journal français d'ophtalmologie·L KodjikianG Berdeaux
Sep 25, 2007·Journal of Cataract and Refractive Surgery·Terrence P O'BrienFrancis S Mah
Oct 31, 2006·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Kim UshaRahul Kelkar
Nov 1, 2005·Survey of Ophthalmology·Barry A Schlech, Eduardo Alfonso
Sep 1, 2005·Journal of Cataract and Refractive Surgery·Majid MoshirfarGaren Mirzaian
Jan 24, 2014·ISRN Pharmacology·Pradeep R JadhavYeshwant A Deshmukh
Aug 25, 2016·International Journal of Antimicrobial Agents·Andreana MarinoGiuseppe Bisignano
Aug 10, 2010·Journal of Cataract and Refractive Surgery·Marguerite McDonald, Joseph M Blondeau
Jul 31, 2007·Journal of Cataract and Refractive Surgery·Vishal JhanjiJeewan Titiyal
Sep 15, 2010·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Paul KarpeckiTimothy L Comstock
Sep 26, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Richard G FiscellaMichael K Jensen
Oct 25, 2006·International Ophthalmology Clinics·Randall Olson
Sep 12, 2009·Expert Opinion on Pharmacotherapy·Joseph S Bertino, Jin-Zhong Zhang
Aug 5, 2016·Cornea·Francisco Bandeira E SilvaFabio Ramos de Souza Carvalho
Dec 23, 2016·Journal of Cataract and Refractive Surgery·Steve A Arshinoff, Milad Modabber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.